Acute Promyelocytic Leukemia (APL)
Also known as: Acute Promyelocytic Leukemia / Leukemia, Promyelocytic, Acute / Acute promyelocytic leukaemia / Acute promyelocytic leukemia, not having achieved remission / Disorder: Acute promyelocytic leukemia, FAB M3 (disorder) / Acute promyelocytic leukemia with PML::RARA fusion (morphologic abnormality)
Drug | Drug Name | Drug Description |
---|---|---|
DB01169 | Arsenic trioxide | A chemotherapeutic agent used in the treatment of refractory or relapsed acute promyelocytic leukemia in patients with prior retinoid and anthracycline chemotherapy. |
DB00987 | Cytarabine | A pyrimidine nucleoside analogue used to treat acute non-lymphocytic leukemia, lymphocytic leukemia, and the blast phase of chronic myelocytic leukemia. |
DB01033 | Mercaptopurine | An antineoplastic agent used to treat acute lymphocytic leukemia. |
DB00563 | Methotrexate | An antineoplastic agent used the treatment of a wide variety of cancers as well as severe psoriasis, severe rheumatoid arthritis, and juvenile rheumatoid arthritis. |
DB01204 | Mitoxantrone | A chemotherapeutic agent used for the treatment of secondary progressive, progressive relapsing, or worsening relapsing-remitting multiple sclerosis. |